Neal J. Thomas
Photo
Academic title Assistant Professor of Pediatrics
College College of Medicine
Campuses Penn State Milton S. Hershey Medical Center
Department Pediatrics
Graduate programs
Email Phone FAX
  nthomas@psu.edu
  717 531 5337
  717 531 0809
Educational background
  M.D., Temple University School of Medicine, 1991
Residency, Medical University of South Carolina
Fellowship, Children's Hospital of Pittsburgh
Research interests
 

Type IV phosphodiesterase inhibition


Pediatric critical care clinical trials


Inflammation after brain injury or infection


Shock/sepsis


Surfactant


Surfactant protein genetic variants in critical illness

Areas of expertise
 
ColloidsPlasma Substitutes
SepsisDefensins
Lactoferrin3',5'-Cyclic-AMP Phosphodiesterases
Glomerular Filtration RateMultiple Organ Failure
Phosphodiesterase InhibitorsRenal Circulation
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinoneSplanchnic Circulation
CatecholaminesHemodynamics
ShockVascular Resistance
Extracorporeal Membrane OxygenationEndotoxemia
KidneyMesentery
NorepinephrineRegional Blood Flow
Magnesium SulfateMuscle Rigidity
SpasmTetanus
AlgorithmsHypnotics and Sedatives
Intensive Care Units, PediatricIntubation, Intratracheal
Risk ManagementAmantadine
Antiviral AgentsCerebrospinal Fluid
Encephalitis, ViralInfluenza, Human
Influenza A virusBurnout, Professional
Critical IllnessMedical Staff, Hospital
Clostridium perfringensGas Gangrene
Heart FailureHemolytic-Uremic Syndrome
Biological ProductsIntensive Care
Pulmonary SurfactantsRespiration, Artificial
Respiratory InsufficiencyIntrons
Pulmonary Surfactant-Associated Protein BRNA Splicing
Regulatory Sequences, Ribonucleic AcidSequence Deletion
Critical CarePractice Guidelines as Topic
Enteral NutritionIntubation, Gastrointestinal
Cardiopulmonary ResuscitationBaseball
Death, Sudden, CardiacDefibrillators
Electric CountershockTachycardia, Ventricular
Ethnic GroupsWounds and Injuries
Antibodies, MonoclonalBone Marrow Transplantation
Decision Support TechniquesImmunocompromised Host
Respiratory Syncytial Virus InfectionsEducation, Medical
ParentsChild Abuse
Health EducationNational Health Programs
Precursor Cell Lymphoblastic Leukemia-LymphomaAnoxia
DNA FingerprintingDNA Methylation
Oligonucleotide Array Sequence AnalysisCraniocerebral Trauma
Publication author name
  Thomas NJ
Select publications
  Khandelwal P. Bohn D. Carcillo JA. Thomas NJ. Pro/con clinical debate: do colloids have advantages over crystalloids in paediatric sepsis? 2002 Aug. Crit Care. 6(4):286-8.
Thomas NJ. Carcillo JA. Doughty LA. Sasser H. Heine RP. Plasma concentrations of defensins and lactoferrin in children with severe sepsis. 2002 Jan. Pediatr Infect Dis J. 21(1):34-8.
National Center for Research Resources
Thomas NJ. Carcillo JA. Herzer WA. Mi Z. Jackson EK. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine. 2001 Jan. J Pharmacol Exp Ther. 296(1):168-74.
National Heart, Lung, and Blood Institute
Thomas NJ. Herzer WA. Carcillo JA. Jackson EK. Effect of the type IV phosphodiesterase inhibitor Ro 20-1724 on catecholamine-induced alterations in regional vascular resistance and regional blood flow. 1998 Jun. J Cardiovasc Pharmacol. 31(6):840-53.
National Center for Research Resources
National Heart, Lung, and Blood Institute
Tecklenburg FW. Thomas NJ. Webb SA. Case C. Habib DM. Pediatric ECMO for severe quinidine cardiotoxicity. 1997 Apr. Pediatr Emerg Care. 13(2):111-3.
also ...
 All publications